Viridian Therapeutics
VRDN
VRDN
56 hedge funds and large institutions have $44.5M invested in Viridian Therapeutics in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
37% less capital invested
Capital invested by funds: $71M → $44.5M (-$26.5M)
Holders
56
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.14M | |
| 2 | +$475K | |
| 3 | +$440K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$399K |
| 5 |
Morgan Stanley
New York
|
+$214K |
Top Sellers
| 1 | -$3.06M | |
| 2 | -$2.88M | |
| 3 | -$1.32M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$959K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$744K |